Uniplan Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-82,776
Closed -$8.22M 137
2019
Q3
$8.22M Buy
82,776
+1,525
+2% +$145K 0.51% 46
2019
Q2
$7.51M Sell
81,251
-108
-0.1% -$10.3K 0.48% 51
2019
Q1
$7.67M Buy
+81,359
New +$7.12M 0.49% 46

Other funds holding CELG

Uniplan Investment Counsel's CELG Position: Q4 2019 in Review

Uniplan Investment Counsel sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 82,776 shares — an estimated $8.22M sold.

Uniplan Investment Counsel first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $8.22M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Uniplan Investment Counsel reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Uniplan Investment Counsel sold 82,776 Celgene Corp shares in Q4 2019, an estimated $8.22M.
  • Uniplan Investment Counsel first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Uniplan Investment Counsel's Celgene Corp position peaked at $8.22M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Uniplan Investment Counsel's 13F filing for Q4 2019, filed 14 Feb 2020.